APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Biologics for CRSwNP

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Biologics for CRSwNP Industry Growth and Trends Forecast to 2032

Report ID 173970740128 December 202595 pages

Choose your research edition.

Industry ResearchBiologics for CRSwNP Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologics for CRSwNP Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Biologics for CRSwNP Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologics for CRSwNP Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologics for CRSwNP Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Biologics for CRSwNP market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biologics for CRSwNP is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biologics for CRSwNP is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologics for CRSwNP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biologics for CRSwNP include Genentech, Regeneron, GSK, Novartis and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biologics for CRSwNP market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biologics for CRSwNP market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biologics for CRSwNP market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biologics for CRSwNP.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Biologics for CRSwNP market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biologics for CRSwNP Market by Company

Genentech

Regeneron

GSK

Novartis

Sanofi

Biologics for CRSwNP Segment by Type

Mepolizumab

Dupilumab

Omalizumab

Biologics for CRSwNP Segment by Application

Hospital

Clinic

Other

Biologics for CRSwNP Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologics for CRSwNP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologics for CRSwNP and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologics for CRSwNP.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biologics for CRSwNP manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Biologics for CRSwNP in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Mepolizumab Table 2. Major Company of Dupilumab Table 3. Major Company of Omalizumab Table 4. Global Biologics for CRSwNP Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Biologics for CRSwNP Sales by Type (2021-2026) & (K Units) Table 6. Global Biologics for CRSwNP Sales Market Share in Volume by Type (2021-2026) Table 7. Global Biologics for CRSwNP Sales by Type (2021-2026) & (US$ Million) Table 8. Global Biologics for CRSwNP Sales Market Share in Value by Type (2021-2026) Table 9. Global Biologics for CRSwNP Price by Type (2021-2026) & (US$/Unit) Table 10. Global Biologics for CRSwNP Sales by Type (2027-2032) & (K Units) Table 11. Global Biologics for CRSwNP Sales Market Share in Volume by Type (2027-2032) Table 12. Global Biologics for CRSwNP Sales by Type (2027-2032) & (US$ Million) Table 13. Global Biologics for CRSwNP Sales Market Share in Value by Type (2027-2032) Table 14. Global Biologics for CRSwNP Price by Type (2027-2032) & (US$/Unit) Table 15. North America Biologics for CRSwNP Sales by Type (2021-2026) & (K Units) Table 16. North America Biologics for CRSwNP Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Biologics for CRSwNP Sales by Type (2021-2026) & (K Units) Table 18. Europe Biologics for CRSwNP Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Biologics for CRSwNP Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Biologics for CRSwNP Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Biologics for CRSwNP Sales by Type (2021-2026) & (K Units) Table 22. Latin America Biologics for CRSwNP Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Biologics for CRSwNP Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Biologics for CRSwNP Sales by Type (2021-2026) & (US$ Million) Table 25. Biologics for CRSwNP Industry Trends Table 26. Biologics for CRSwNP Industry Drivers Table 27. Biologics for CRSwNP Industry Opportunities and Challenges Table 28. Biologics for CRSwNP Industry Restraints Table 29. Global Biologics for CRSwNP Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Biologics for CRSwNP Revenue Market Share by Company (2021-2026) Table 31. Global Biologics for CRSwNP Sales by Company (2021-2026) & (K Units) Table 32. Global Biologics for CRSwNP Sales Share by Company (2021-2026) Table 33. Global Biologics for CRSwNP Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Biologics for CRSwNP Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Biologics for CRSwNP Major Company Production Sites and Headquarters Table 36. Global Biologics for CRSwNP Company, Product Type & Application Table 37. Global Biologics for CRSwNP Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Biologics for CRSwNP by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Biologics for CRSwNP Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Biologics for CRSwNP Sales by Region (2021-2026) & (K Units) Table 42. Global Biologics for CRSwNP Sales Market Share in Volume by Region (2021-2026) Table 43. Global Biologics for CRSwNP Sales by Region (2021-2026) & (US$ Million) Table 44. Global Biologics for CRSwNP Sales Market Share in Value by Region (2021-2026) Table 45. Global Biologics for CRSwNP Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Biologics for CRSwNP Sales by Region (2027-2032) & (K Units) Table 47. Global Biologics for CRSwNP Sales Market Share in Volume by Region (2027-2032) Table 48. Global Biologics for CRSwNP Sales by Region (2027-2032) & (US$ Million) Table 49. Global Biologics for CRSwNP Sales Market Share in Value by Region (2027-2032) Table 50. Global Biologics for CRSwNP Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Biologics for CRSwNP Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Biologics for CRSwNP Sales by Application (2021-2026) & (K Units) Table 53. Global Biologics for CRSwNP Sales Market Share in Volume by Application (2021-2026) Table 54. Global Biologics for CRSwNP Sales by Application (2021-2026) & (US$ Million) Table 55. Global Biologics for CRSwNP Sales Market Share in Value by Application (2021-2026) Table 56. Global Biologics for CRSwNP Price by Application (2021-2026) & (US$/Unit) Table 57. Global Biologics for CRSwNP Sales by Application (2027-2032) & (K Units) Table 58. Global Biologics for CRSwNP Sales Market Share in Volume by Application (2027-2032) Table 59. Global Biologics for CRSwNP Sales by Application (2027-2032) & (US$ Million) Table 60. Global Biologics for CRSwNP Sales Market Share in Value by Application (2027-2032) Table 61. Global Biologics for CRSwNP Price by Application (2027-2032) & (US$/Unit) Table 62. North America Biologics for CRSwNP Sales by Application (2021-2026) & (K Units) Table 63. North America Biologics for CRSwNP Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Biologics for CRSwNP Sales by Application (2021-2026) & (K Units) Table 65. Europe Biologics for CRSwNP Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Biologics for CRSwNP Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Biologics for CRSwNP Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Biologics for CRSwNP Sales by Application (2021-2026) & (K Units) Table 69. Latin America Biologics for CRSwNP Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Biologics for CRSwNP Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Biologics for CRSwNP Sales by Application (2021-2026) & (US$ Million) Table 72. Genentech Company Information Table 73. Genentech Business Overview Table 74. Genentech Biologics for CRSwNP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Genentech Biologics for CRSwNP Product Portfolio Table 76. Genentech Recent Development Table 77. Regeneron Company Information Table 78. Regeneron Business Overview Table 79. Regeneron Biologics for CRSwNP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Regeneron Biologics for CRSwNP Product Portfolio Table 81. Regeneron Recent Development Table 82. GSK Company Information Table 83. GSK Business Overview Table 84. GSK Biologics for CRSwNP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. GSK Biologics for CRSwNP Product Portfolio Table 86. GSK Recent Development Table 87. Novartis Company Information Table 88. Novartis Business Overview Table 89. Novartis Biologics for CRSwNP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Novartis Biologics for CRSwNP Product Portfolio Table 91. Novartis Recent Development Table 92. Sanofi Company Information Table 93. Sanofi Business Overview Table 94. Sanofi Biologics for CRSwNP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sanofi Biologics for CRSwNP Product Portfolio Table 96. Sanofi Recent Development Table 97. North America Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 98. North America Biologics for CRSwNP Sales by Country (2021-2026) & (K Units) Table 99. North America Biologics for CRSwNP Sales Market Share by Country (2021-2026) Table 100. North America Biologics for CRSwNP Sales Forecast by Country (2027-2032) & (K Units) Table 101. North America Biologics for CRSwNP Sales Market Share Forecast by Country (2027-2032) Table 102. North America Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. North America Biologics for CRSwNP Market Size by Country (2021-2026) & (US$ Million) Table 104. North America Biologics for CRSwNP Market Share by Country (2021-2026) Table 105. North America Biologics for CRSwNP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. North America Biologics for CRSwNP Market Share Forecast by Country (2027-2032) Table 107. Europe Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. Europe Biologics for CRSwNP Sales by Country (2021-2026) & (K Units) Table 109. Europe Biologics for CRSwNP Sales Market Share by Country (2021-2026) Table 110. Europe Biologics for CRSwNP Sales Forecast by Country (2027-2032) & (K Units) Table 111. Europe Biologics for CRSwNP Sales Market Share Forecast by Country (2027-2032) Table 112. Europe Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Europe Biologics for CRSwNP Market Size by Country (2021-2026) & (US$ Million) Table 114. Europe Biologics for CRSwNP Market Share by Country (2021-2026) Table 115. Europe Biologics for CRSwNP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Europe Biologics for CRSwNP Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Biologics for CRSwNP Sales by Country (2021-2026) & (K Units) Table 119. Asia-Pacific Biologics for CRSwNP Sales Market Share by Country (2021-2026) Table 120. Asia-Pacific Biologics for CRSwNP Sales Forecast by Country (2027-2032) & (K Units) Table 121. Asia-Pacific Biologics for CRSwNP Sales Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Biologics for CRSwNP Market Size by Country (2021-2026) & (US$ Million) Table 124. Asia-Pacific Biologics for CRSwNP Market Share by Country (2021-2026) Table 125. Asia-Pacific Biologics for CRSwNP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Asia-Pacific Biologics for CRSwNP Market Share Forecast by Country (2027-2032) Table 127. Latin America Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Latin America Biologics for CRSwNP Sales by Country (2021-2026) & (K Units) Table 129. Latin America Biologics for CRSwNP Sales Market Share by Country (2021-2026) Table 130. Latin America Biologics for CRSwNP Sales Forecast by Country (2027-2032) & (K Units) Table 131. Latin America Biologics for CRSwNP Sales Market Share Forecast by Country (2027-2032) Table 132. Latin America Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Latin America Biologics for CRSwNP Market Size by Country (2021-2026) & (US$ Million) Table 134. Latin America Biologics for CRSwNP Market Share by Country (2021-2026) Table 135. Latin America Biologics for CRSwNP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Latin America Biologics for CRSwNP Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Biologics for CRSwNP Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Biologics for CRSwNP Sales Market Share by Country (2021-2026) Table 140. Middle East and Africa Biologics for CRSwNP Sales Forecast by Country (2027-2032) & (K Units) Table 141. Middle East and Africa Biologics for CRSwNP Sales Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Biologics for CRSwNP Market Size by Country (2021-2026) & (US$ Million) Table 144. Middle East and Africa Biologics for CRSwNP Market Share by Country (2021-2026) Table 145. Middle East and Africa Biologics for CRSwNP Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Middle East and Africa Biologics for CRSwNP Market Share Forecast by Country (2027-2032) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Biologics for CRSwNP Distributors List Table 150. Biologics for CRSwNP Customers List Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Biologics for CRSwNP Image Figure 2. Global Biologics for CRSwNP Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologics for CRSwNP Market Size (2021-2032) & (US$ Million) Figure 4. Global Biologics for CRSwNP Sales (2021-2032) & (K Units) Figure 5. Mepolizumab Image Figure 6. Global Mepolizumab Sales YoY Growth (2021-2032) & (K Units) Figure 7. Dupilumab Image Figure 8. Global Dupilumab Sales YoY Growth (2021-2032) & (K Units) Figure 9. Omalizumab Image Figure 10. Global Omalizumab Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Biologics for CRSwNP Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Biologics for CRSwNP Market Share by Type 2025 VS 2032 Figure 13. North America Biologics for CRSwNP Sales Market Share in Volume by Type in 2025 Figure 14. North America Biologics for CRSwNP Sales Market Share in Value by Type in 2025 Figure 15. Europe Biologics for CRSwNP Sales Market Share in Volume by Type in 2025 Figure 16. Europe Biologics for CRSwNP Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Biologics for CRSwNP Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Biologics for CRSwNP Sales Market Share in Value by Type in 2025 Figure 19. Latin America Biologics for CRSwNP Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Biologics for CRSwNP Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Biologics for CRSwNP Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Biologics for CRSwNP Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Biologics for CRSwNP Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Biologics for CRSwNP Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Biologics for CRSwNP Market Share by Application 2025 VS 2032 Figure 33. North America Biologics for CRSwNP Sales Market Share in Volume by Application in 2025 Figure 34. North America Biologics for CRSwNP Sales Market Share in Value by Application in 2025 Figure 35. Europe Biologics for CRSwNP Sales Market Share in Volume by Application in 2025 Figure 36. Europe Biologics for CRSwNP Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Biologics for CRSwNP Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Biologics for CRSwNP Sales Market Share in Value by Application in 2025 Figure 39. Latin America Biologics for CRSwNP Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Biologics for CRSwNP Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Biologics for CRSwNP Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Biologics for CRSwNP Sales Market Share in Value by Application in 2025 Figure 43. North America Biologics for CRSwNP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Biologics for CRSwNP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Biologics for CRSwNP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Biologics for CRSwNP Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Biologics for CRSwNP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Biologics for CRSwNP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Biologics for CRSwNP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Biologics for CRSwNP Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Biologics for CRSwNP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Biologics for CRSwNP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Biologics for CRSwNP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Biologics for CRSwNP Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Biologics for CRSwNP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Biologics for CRSwNP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Biologics for CRSwNP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Biologics for CRSwNP Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Biologics for CRSwNP Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Biologics for CRSwNP Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Biologics for CRSwNP Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Biologics for CRSwNP Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Biologics for CRSwNP Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Biologics for CRSwNP Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Mepolizumab
  • Dupilumab
  • Omalizumab
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Genentech
  • Regeneron
  • GSK
  • Novartis
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biologics for CRSwNP Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Biologics for CRSwNP Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Biologics for CRSwNP Market by Type
  6. 1.3.1 Mepolizumab
  7. 1.3.2 Dupilumab
  8. 1.3.3 Omalizumab
  9. 1.4 Global Biologics for CRSwNP Market Size by Type
  10. 1.4.1 Global Biologics for CRSwNP Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Biologics for CRSwNP Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Biologics for CRSwNP Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Biologics for CRSwNP Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Biologics for CRSwNP Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Biologics for CRSwNP Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Biologics for CRSwNP Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Biologics for CRSwNP Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Biologics for CRSwNP Industry Trends
  2. 2.2 Biologics for CRSwNP Industry Drivers
  3. 2.3 Biologics for CRSwNP Industry Opportunities and Challenges
  4. 2.4 Biologics for CRSwNP Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Biologics for CRSwNP Revenue (2021-2026)
  2. 3.2 Global Top Players by Biologics for CRSwNP Sales (2021-2026)
  3. 3.3 Global Top Players by Biologics for CRSwNP Price (2021-2026)
  4. 3.4 Global Biologics for CRSwNP Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biologics for CRSwNP Major Company Production Sites & Headquarters
  6. 3.6 Global Biologics for CRSwNP Company, Product Type & Application
  7. 3.7 Global Biologics for CRSwNP Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biologics for CRSwNP Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biologics for CRSwNP Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biologics for CRSwNP Tier 1, Tier 2, and Tier 3
4 Biologics for CRSwNP Regional Status and Outlook
  1. 4.1 Global Biologics for CRSwNP Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Biologics for CRSwNP Historic Market Size by Region
  3. 4.2.1 Global Biologics for CRSwNP Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Biologics for CRSwNP Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Biologics for CRSwNP Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Biologics for CRSwNP Forecasted Market Size by Region
  7. 4.3.1 Global Biologics for CRSwNP Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Biologics for CRSwNP Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Biologics for CRSwNP Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Biologics for CRSwNP by Application
  1. 5.1 Biologics for CRSwNP Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Biologics for CRSwNP Market Size by Application
  6. 5.2.1 Global Biologics for CRSwNP Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Biologics for CRSwNP Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Biologics for CRSwNP Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Biologics for CRSwNP Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Biologics for CRSwNP Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Biologics for CRSwNP Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Biologics for CRSwNP Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Biologics for CRSwNP Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Genentech
  2. 6.1.1 Genentech Company Information
  3. 6.1.2 Genentech Business Overview
  4. 6.1.3 Genentech Biologics for CRSwNP Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Genentech Biologics for CRSwNP Product Portfolio
  6. 6.1.5 Genentech Recent Developments
  7. 6.2 Regeneron
  8. 6.2.1 Regeneron Company Information
  9. 6.2.2 Regeneron Business Overview
  10. 6.2.3 Regeneron Biologics for CRSwNP Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Regeneron Biologics for CRSwNP Product Portfolio
  12. 6.2.5 Regeneron Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Biologics for CRSwNP Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Biologics for CRSwNP Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Biologics for CRSwNP Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Biologics for CRSwNP Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Biologics for CRSwNP Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Biologics for CRSwNP Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Biologics for CRSwNP Sales by Country
  2. 7.1.1 North America Biologics for CRSwNP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Biologics for CRSwNP Sales by Country (2021-2026)
  4. 7.1.3 North America Biologics for CRSwNP Sales Forecast by Country (2027-2032)
  5. 7.2 North America Biologics for CRSwNP Market Size by Country
  6. 7.2.1 North America Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Biologics for CRSwNP Market Size by Country (2021-2026)
  8. 7.2.3 North America Biologics for CRSwNP Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Biologics for CRSwNP Sales by Country
  2. 8.1.1 Europe Biologics for CRSwNP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Biologics for CRSwNP Sales by Country (2021-2026)
  4. 8.1.3 Europe Biologics for CRSwNP Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Biologics for CRSwNP Market Size by Country
  6. 8.2.1 Europe Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Biologics for CRSwNP Market Size by Country (2021-2026)
  8. 8.2.3 Europe Biologics for CRSwNP Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Biologics for CRSwNP Sales by Country
  2. 9.1.1 Asia-Pacific Biologics for CRSwNP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Biologics for CRSwNP Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Biologics for CRSwNP Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Biologics for CRSwNP Market Size by Country
  6. 9.2.1 Asia-Pacific Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Biologics for CRSwNP Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Biologics for CRSwNP Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Biologics for CRSwNP Sales by Country
  2. 10.1.1 South America Biologics for CRSwNP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Biologics for CRSwNP Sales by Country (2021-2026)
  4. 10.1.3 South America Biologics for CRSwNP Sales Forecast by Country (2027-2032)
  5. 10.2 South America Biologics for CRSwNP Market Size by Country
  6. 10.2.1 South America Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Biologics for CRSwNP Market Size by Country (2021-2026)
  8. 10.2.3 South America Biologics for CRSwNP Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Biologics for CRSwNP Sales by Country
  2. 11.1.1 Middle East and Africa Biologics for CRSwNP Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Biologics for CRSwNP Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Biologics for CRSwNP Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Biologics for CRSwNP Market Size by Country
  6. 11.2.1 Middle East and Africa Biologics for CRSwNP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Biologics for CRSwNP Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Biologics for CRSwNP Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Biologics for CRSwNP Value Chain Analysis
  2. 12.1.1 Biologics for CRSwNP Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Biologics for CRSwNP Production Mode & Process
  7. 12.2 Biologics for CRSwNP Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Biologics for CRSwNP Distributors
  10. 12.2.3 Biologics for CRSwNP Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst